Skip to content

Clinical trials

Ocular Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Country / region: Japan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20113
20131
20144
20151
20162
20171
20191
20202
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Santen Pharmaceutical Co., Ltd.10
Otsuka Pharmaceutical Co., Ltd.3
Aerie Pharmaceuticals2
Alcon Research2
AbbVie1
Alcon, a Novartis Company1
Bausch & Lomb Incorporated1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Santen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension22
Glaucoma, Open-Angle17
Glaucoma8
Hypertension1
Low Tension Glaucoma1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.